| http://dbpedia.org/ontology/abstract
|
Tisotumab vedotin, sold under the brand na … Tisotumab vedotin, sold under the brand name Tivdak, is an antibody-drug conjugate used to treat cervical cancer. It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. Tisotumab vedotin was approved for medical use in the United States in September 2021. It is administered by infusion into a vein. Tisotumab vedotin is the international nonproprietary name. is the international nonproprietary name.
, Tisotumab-Vedotin (internationaler Freinam … Tisotumab-Vedotin (internationaler Freiname) ist ein Arzneistoff aus der Gruppe der Antikörper-Wirkstoff-Konjugate. Er wurde in den USA im September 2021 unter dem Namen Tivdak (Seagen Inc.) zugelassen für die Behandlung von Patientinnen mit rezidivierendem oder metastasierendem Gebärmutterhalskrebs während oder nach einer Chemotherapie. Der Wirkstoff wird intravenös verabreicht.Der Wirkstoff wird intravenös verabreicht.
, Тизотумаб-ведотин (лат. tisotumab vedotin) — конъюгат антитело-препарат для лечения рака шейки матки. В 2021 году препарат одобрен в ускоренном порядке для применения в США.
|
| http://dbpedia.org/ontology/alternativeName
|
Tivdak
|
| http://dbpedia.org/ontology/casNumber
|
1418731-10-8
|
| http://dbpedia.org/ontology/class
|
http://dbpedia.org/resource/Antineoplastic +
|
| http://dbpedia.org/ontology/fdaUniiCode
|
T41737F88A
|
| http://dbpedia.org/ontology/kegg
|
D11814
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://druginfo.nlm.nih.gov/drugportal/name/tisotumab%20vedotin +
|
| http://dbpedia.org/ontology/wikiPageID
|
68778849
|
| http://dbpedia.org/ontology/wikiPageLength
|
7867
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1123507863
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Liver +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Apoptosis +
, http://dbpedia.org/resource/Intravenous_therapy +
, http://dbpedia.org/resource/Antibody-drug_conjugate +
, http://dbpedia.org/resource/Infusion_therapy +
, http://dbpedia.org/resource/Pneumonitis +
, http://dbpedia.org/resource/Cervical_cancer +
, http://dbpedia.org/resource/Peripheral_neuropathy +
, http://dbpedia.org/resource/Utrecht +
, http://dbpedia.org/resource/Copenhagen +
, http://dbpedia.org/resource/Black_box_warning +
, http://dbpedia.org/resource/Monomethyl_auristatin_E +
, http://dbpedia.org/resource/Antineoplastic +
, http://dbpedia.org/resource/Wikt:oculotoxic +
, http://dbpedia.org/resource/Category:Antibody-drug_conjugates +
, http://dbpedia.org/resource/Mitotic_inhibitor +
, http://dbpedia.org/resource/International_nonproprietary_name +
, http://dbpedia.org/resource/Blepharitis +
, http://dbpedia.org/resource/CYP3A4 +
, http://dbpedia.org/resource/Intravenous +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
, http://dbpedia.org/resource/Dry_eye +
, http://dbpedia.org/resource/Genmab +
, http://dbpedia.org/resource/Conjunctivitis +
, http://dbpedia.org/resource/Clinical_trials +
, http://dbpedia.org/resource/Induced_cell_cycle_arrest +
, http://dbpedia.org/resource/Epistaxis +
, http://dbpedia.org/resource/Proteolysis +
, http://dbpedia.org/resource/Cornea +
, http://dbpedia.org/resource/Tissue_factor +
|
| http://dbpedia.org/property/atcPrefix
|
None
|
| http://dbpedia.org/property/casNumber
|
1418731
|
| http://dbpedia.org/property/class
|
http://dbpedia.org/resource/Antineoplastic +
|
| http://dbpedia.org/property/dailymedid
|
Tisotumab_vedotin
|
| http://dbpedia.org/property/eliminationHalfLife
|
345600.0
|
| http://dbpedia.org/property/excretion
|
Fecal, renal
|
| http://dbpedia.org/property/kegg
|
D11814
|
| http://dbpedia.org/property/legalUs
|
Rx-only
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/metabolism
|
Hepatic, by CYP3A4
|
| http://dbpedia.org/property/metabolites
|
http://dbpedia.org/resource/Monomethyl_auristatin_E +
|
| http://dbpedia.org/property/pregnancyCategory
|
Contraindicated
|
| http://dbpedia.org/property/proteinBound
|
68
|
| http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Intravenous +
|
| http://dbpedia.org/property/source
|
u
|
| http://dbpedia.org/property/synonyms
|
Tisotumab vedotin-tftv
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/Tissue_factor +
|
| http://dbpedia.org/property/tradename
|
Tivdak
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
T41737F88A
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Use_American_English +
, http://dbpedia.org/resource/Template:Pharma-stub +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Monoclonals_for_tumors +
, http://dbpedia.org/resource/Template:Portal_bar +
, http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Main +
, http://dbpedia.org/resource/Template:ClinicalTrialsGov +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
, http://dbpedia.org/resource/Category:Antibody-drug_conjugates +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Tisotumab_vedotin?oldid=1123507863&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Tisotumab_vedotin +
|
| owl:sameAs |
http://dbpedia.org/resource/Tisotumab_vedotin +
, https://global.dbpedia.org/id/G8UaW +
, http://de.dbpedia.org/resource/Tisotumab-Vedotin +
, http://www.wikidata.org/entity/Q108670929 +
, http://ru.dbpedia.org/resource/%D0%A2%D0%B8%D0%B7%D0%BE%D1%82%D1%83%D0%BC%D0%B0%D0%B1-%D0%B2%D0%B5%D0%B4%D0%BE%D1%82%D0%B8%D0%BD +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
Tisotumab vedotin, sold under the brand na … Tisotumab vedotin, sold under the brand name Tivdak, is an antibody-drug conjugate used to treat cervical cancer. It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. Tisotumab vedotin was approved for medical use in the United States in September 2021. It is administered by infusion into a vein. Tisotumab vedotin is the international nonproprietary name. is the international nonproprietary name.
, Tisotumab-Vedotin (internationaler Freinam … Tisotumab-Vedotin (internationaler Freiname) ist ein Arzneistoff aus der Gruppe der Antikörper-Wirkstoff-Konjugate. Er wurde in den USA im September 2021 unter dem Namen Tivdak (Seagen Inc.) zugelassen für die Behandlung von Patientinnen mit rezidivierendem oder metastasierendem Gebärmutterhalskrebs während oder nach einer Chemotherapie. Der Wirkstoff wird intravenös verabreicht.Der Wirkstoff wird intravenös verabreicht.
, Тизотумаб-ведотин (лат. tisotumab vedotin) — конъюгат антитело-препарат для лечения рака шейки матки. В 2021 году препарат одобрен в ускоренном порядке для применения в США.
|
| rdfs:label |
Tisotumab vedotin
, Тизотумаб-ведотин
, Tisotumab-Vedotin
|
